Home World News Adding Apalutamide to Perioperative ADT Associated with Better Outcomes of Radical Prostatectomy... World News Adding Apalutamide to Perioperative ADT Associated with Better Outcomes of Radical Prostatectomy for High-Risk Localised or Locally Advanced Prostate Cancer By Ogkologos - June 3, 2026 269 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PROTEUS study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR On your marks, get set… start-up! August 13, 2021 Breast Cancer Patient Given 2 Years to Live is Now a... May 28, 2021 ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ February 3, 2021 Teen’s Innovative “SMART Armour” Protects Breast Cancer Patients from Radiation May 31, 2019 Load more HOT NEWS ESMO Clinical Practice Guideline Express Update on daraxonrasib in the treatment... EMA Recommends Granting a Conditional Marketing Authorisation for Odronextamab CD19-Directed CAR T-Cell Therapy Leads to Exceptionally Long Remissions in Some... FDA Approves Trifluridine and Tipiracil with Bevacizumab for Previously Treated Metastatic...
